| 10009473 |
1,2-dipalmitoyl-sn-glycero-3-PC
|
|
63-89-8 |
>98%
|
|
|
2007-01-19
|
7.301464088397
|
1-2-dipalmitoyl-sn-glycero-3-pc
|
L-dipalmitoyl Lecithin; L-DPPC; 1,2-dipalmitoyl-sn-glycero-3-Phosphatidylcholine
|
antigens phosphatidylcholines zwitterionic phosphoglycerides proteoliposomes liposomal enzymes g-glutamyl gamma-glutamyl .gamma.-glutamyl transpeptidase erythrocytes immunotherapy immunotherapies GSLs glycosphingolipids phospholipids polyenylphosphatidylcholine |
7.301464088397
|
| 10312 |
8,12-iso-iPF2α-VI-1,5-lactone
Exclusive |
|
- |
≥98%
|
|
✓ |
2009-08-07
|
6.250128913443
|
8-12-iso-ipf2-vi-1-5-lactone
|
|
lactone IPF2α -I iPF2α-VI F2-iP urine lipid peroxidation plasma biomarker oxidative stress 214894-81-2 214894-83-4 |
6.250128913443
|
| 11001 |
Anatabine
New |
|
2743-90-0 |
≥95%
|
|
|
2011-11-10
|
0.311827956989
|
anatabine
|
|
alkaloids solanaceae tobacco Alzheimer’s diseases amyloid beta Aβ β-secretase BACE-1 NF-κB inflammation urine nicotine transcription proteins SHSY-5Y cells |
0.311827956989
|
| 13662 |
Arecoline (hydrobromide)
|
|
300-08-3 |
≥95%
|
|
|
2010-08-19
|
0.299079189687
|
arecoline-hydrobromide
|
|
63-75-2 alkaloids betel nuts Areca agonists muscarinic acetylcholine receptors M1 M2 M3 M4 M5 smooth muscles contractions learning memory dementia Alzheimer’s diseases Methylarecaidin Arecholine Arecoline Arecholin Arecaline Arecolin |
0.299079189687
|
| 600140 |
Autophagy/Cytotoxicity Dual Staining Kit
|
|
- |
|
|
|
2009-07-14
|
84.406214941364
|
autophagy-cytotoxicity-dual-staining-kit
|
|
assays kits measuring measurement MDC cell-based autophagy cells cytotoxicity staining autofluorescent autofluorescence substances multilamellar body bodies ions trapping mechanisms membranes lipids probes autophagic vacuoles cultured degradation digestion intracellular lysosomes organelles misfolded proteins microorganisms cytoplasms double membranes autophagosomes autolysosomes homeostasis dysregulation cancers infections aging degenerative diseases stress death apoptosis |
84.406214941364
|
| 10009021 |
AVE-1625
Exclusive |
|
358970-97-5 |
>98%
|
|
✓ |
2008-04-03
|
121.810082872928
|
ave-1625
|
|
cannabinoids CB1 receptors schizophrenia parkinsons disease alzheimers disease metabolism obesity SR-141716 lipolysis glycogenolysis antagonist endocrinology neurochemistry |
121.810082872928
|
| 10227 |
BACE (human recombinant)
|
|
- |
≥95%
|
|
|
2009-03-09
|
18.321469613259
|
bace-human-recombinant
|
Membrane-bound Aspartic Protease; BACE-1; ASP-2; β-Secretase; Memapsin-2
|
proteins amyloids peptides C-terminus terminal alzheimers neurochemistry |
18.321469613259
|
| 600070 |
BACE Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2009-03-26
|
29.692872928176
|
bace-inhibitor-screening-assay-kit
|
β-Secretase Inhibitor Screening Assay Kit
|
inhibitors inhibition inhibits assays kits β-sites .beta.-sites b-sites APP cleaving enzymes β-amyloids .beta.-amyloids b-amyloids peptides Ab A.beta. brain neurodegeneration Alzheimer's Diseases AD proteolytic cleavages precursors β-secretases b-secretases γ-secretases .gamma.-secretases g-secretases membranes aspartic C-terminal C-terminus fragments proteolysis therapeutics therapy cascade pathogenesis mice mouse murine transgenics cholinergic dysfunctions HIV humans fluorescents fluorescences fluorometer assays |
29.692872928176
|
| 10005836 |
bis(7)-Tacrine
|
|
224445-12-9 |
>98%
|
|
|
2005-04-15
|
4.350110497238
|
bis-7-tacrine
|
1,7-N-heptylene-bis-9,9'-amino-1,2,3,4-tetrahydro-acridine
|
dimeric congeners amino acridines inhibits inhibitors inhibition acetylcholinesterases Alzheimer's disease hydrogen peroxides apoptosis pheochromocytoma cells neurochemistry neuroscience |
4.350110497238
|
| 10960 |
Bisdemethoxycurcumin
|
|
24939-16-0 |
≥98%
|
|
|
2011-08-09
|
5.449443726081
|
bisdemethoxycurcumin
|
BDMC
|
curcumin activators macrophages phagocytosis 1α,25-dihydroxyvitamin D, amyloid-β Alzheimer’s diseases cancers transcription genes expression p300 Wnt/β-catenin iNOS inflammation bisdemethoxy curcumin 33171-05-0 |
5.449443726081
|
| 10009536 |
CAY10512
Exclusive |
|
139141-12-1 |
>97%
|
|
✓ |
2007-07-18
|
34.820911602210
|
cay10512
|
|
analogs resveratrol nuclear factors NFkB NF-.kappa.B immunity inflammation stress growth apoptosis trans-stilbene activation cancers NF-kB inhibition inhibtors inhibits atherosclerosis |
34.820911602210
|
| 580110 |
Clusterin (human) EIA Kit
|
|
- |
|
|
|
2011-08-02
|
2.154696132597
|
clusterin-human-eia-kit
|
KUB-1; CLI; SGP-2; AAG4; pADHC-9; TRPM-2; Apo-J; Apolipoprotein J
|
apolipoproteins Up-regulated in Azheimer's diseases brains Ku70-binding proteins 1 sulfated glycoproteins 2 aging-associated genes 4 complement lysis inhibitors testosterone-repressed prostate messages secreted disulfide-linked heterodimeric amyloid lipids bacteria leptin immunoglobulins endocytic receptors LDLs low-density lipoprotein-related LPR2 LPR8 8 endocytosis tissues mammals mammalian cells plasma serums semen cultures media medium developmental remodeling apoptotic neurodegeneration injury stress inhibits inhibition apoptosis carcinogenesis genes CLU ELISAs EIAs enzymes immunoassays kits measures measurements human supernatants |
2.154696132597
|
| 13197 |
DAPT
|
|
208255-80-5 |
≥95%
|
|
|
2010-09-16
|
16.385745856353
|
dapt
|
GSI-IX
|
amyloids precursors proteins APP Notch beta amyloid Aβ Alzheimer’s disease inhibitors inhibits inhibition γ-secretase Aβ42 cells signaling signals differentiation GSIIX GSI IX Dipeptides |
16.385745856353
|
| 10011349 |
Dimebolin (hydrochloride)
|
|
97657-92-6 |
≥98%
|
|
|
2010-02-19
|
10.793650793650
|
dimebolin-hydrochloride
|
|
neurodegeneration Alzheimer's diseases Huntington's neuroprotection cognition inhibitors inhibits inhibition calcium channles β-amyloid β amyloid NMDA glutamate receptors mitochondria dimeboline dimebon neurochemistry neuroscience Indoles |
10.793650793650
|
| 13245 |
Donepezil
|
|
120014-06-4 |
≥95%
|
|
|
2010-03-08
|
3.829033149171
|
donepezil
|
Aricept®
|
acetylcholine neurotransmitters acetylcholinesterase inhibitors inhibits inhibition central nervous system Alzheimer's diseases cognition memory dementia Donezepil signaling signalling AchE CNS behavior (±)-E 2020 (+/-)-E 2020 E2020 |
3.829033149171
|
| 10007963 |
E-64
|
|
66701-25-5 |
≥98%
|
|
|
2009-11-12
|
54.998232044198
|
e-64
|
|
inhibitors cysteine proteases cathepsins papain calpain irreversible inhibition inhibited E64 E 64 |
54.998232044198
|
| 10007964 |
E-64c
|
|
76684-89-4 |
≥98%
|
|
|
2006-08-02
|
52.925580110497
|
e-64c
|
EP 475; Loxistatin Acid; NSC 694279
|
E-64 cysteine protease cell cycle inhibitor E-64d |
52.925580110497
|
| 13314 |
Indirubin-3'-monoxime
|
|
160807-49-8 |
≥98%
|
|
|
2009-07-15
|
12.044033149171
|
indirubin-3-monoxime
|
|
glycogen synthase kinase-3β GSK-3β tau proteins Alzheimer's diseases cyclin-dependent kinases CDK CDK1 cyclin A B E D1 CDK4 CDK2 CDK5 p35 growth proliferation synchronization cells arrest G2/M phases phosphorylation inhibits inhibition inhibitors |
12.044033149171
|
| 600160 |
Methionine Sulfoxide Immunoblotting Kit
|
|
- |
|
|
|
2009-12-17
|
208.421613259668
|
methionine-sulfoxide-immunoblotting-kit
|
MetO Immunoblotting Kit
|
proteins sulfoxides oxidative modifications residues MSRs reactive oxygen species ROSs methionines oxidations reductases sulfones phagocytosis phagocytotic mitochondrias mitochondrial respirations sulfoxidations age-related diseases cellular cells IgG-containing sera Alzheimer's diseases immunoblots immunoblotting western blots blotting kits assays measures measurements detection tissues lysates semi-pure purified reducing non-reducing sample buffers SDS-PAGE rabbit serums immunizations oxidized corn MetO-DZS18 |
208.421613259668
|
| 700140 |
Methyltransferase Colorimetric Assay Kit
|
|
- |
|
|
|
2009-04-07
|
30.658435598239
|
methyltransferase-colorimetric-assay-kit
|
MT Colorimetric Assay Kit
|
assays kits measures measuring monitoring monitors MTs methylation signal transduction biosynthesis repair gene silencing chromatin regulation S-adenosylmethionine SAM-dependent methyltransferases enzymatic cofactors AdoMet donor modifications DNA Alzheimer's diseases depression Parkinson's multiple sclerosis liver failure cancers enzyme-coupled AdoHcy positive control S-adenosylhomocysteine |
30.658435598239
|
| 10230 |
(+)-Muscarine (iodide salt)
|
|
24570-49-8 |
≥95%
|
|
|
2010-05-06
|
0.790883977900
|
-muscarine-iodide-salt
|
|
neurochemistry 300-54-9 2438-77-9 poisonous mushroom acetylcholine G proteins Alzheimer's disease signal transduction L-muscarine Amanita muscaria |
0.790883977900
|
| 13136 |
N-acetyl-D-Glucosamine
|
|
7512-17-6 |
≥98%
|
|
|
2009-03-13
|
57.403001841621
|
n-acetyl-d-glucosamine
|
NAG; Marine Sweet; GlcNAc; NSC 524344
|
monosaccharide glucose O-GlcNAc alzheimer's disease genes expressions chitin cells signalling signaling post-translational modification signal transduction |
57.403001841621
|
| 13055 |
Naphthofluorescein
|
|
61419-02-1 |
≥98%
|
|
|
2009-03-20
|
0.670534069981
|
naphthofluorescein
|
CCG 8295
|
furin matrix metalloproteinase MTA-MMP MMP2 motility invasion cancer metastasis MMP inhibitors naphthafluorescein |
0.670534069981
|
| 13224 |
Neurodazine
Exclusive |
|
937807-66-4 |
≥98%
|
|
✓ |
2009-05-18
|
3.986906077347
|
neurodazine
|
|
neurons neuronal differentiation muscles skeletal myoblasts cells neuron-specific enolase neurofilament 200 synapsin |
3.986906077347
|
| 10009759 |
NMDA Receptor NR2B Subunit (Phospho-Tyr1252) Polyclonal Antibody
|
|
- |
|
|
|
2007-02-09
|
1.582196132596
|
nmda-receptor-nr2b-subunit-phospho-tyr1252-polyclonal-antibody
|
|
antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting |
1.582196132596
|
| 10009760 |
NMDA Receptor NR2B Subunit (Phospho-Tyr1336) Polyclonal Antibody
|
|
- |
|
|
|
2007-02-09
|
1.582196132596
|
nmda-receptor-nr2b-subunit-phospho-tyr1336-polyclonal-antibody
|
|
antibodies WB western blots phospho-specific NMDA receptor NMDAR phosphorylation NR2B blotting immunoblotting |
1.582196132596
|
| 10009761 |
NMDA Receptor NR2B Subunit (Phospho-Tyr1472) Polyclonal Antibody
|
|
- |
|
|
|
2007-02-22
|
5.497941988950
|
nmda-receptor-nr2b-subunit-phospho-tyr1472-polyclonal-antibody
|
|
antibodies WB western blots phospho-specific NMDA receptor phosphorylation NR2B blotting immunoblotting |
5.497941988950
|
| 600240 |
Orexin 1 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive |
|
- |
|
|
✓ |
2010-03-31
|
0.869820441989
|
orexin-1-receptor-step-reporter-assay-kit-luminescence
|
OX1R
|
hypercretins 1 orexins 2 A orexin-2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists |
0.869820441989
|
| 600250 |
Orexin 2 Receptor STEP Reporter Assay Kit (Luminescence)
Exclusive |
|
- |
|
|
✓ |
2010-03-31
|
1.019337016574
|
orexin-2-receptor-step-reporter-assay-kit-luminescence
|
OX2R
|
hypercretins 1 orexin 2 systems regulates regulator sleep wake cycles feeding cardiovascular autonomic hypothalamic neuropeptides Orexins A Orexins B gut hormones secretions hypothalamus midbrains brainstems G protein-coupled receptors GPCRs orexin-1 OX1R orexin-2 OX2R orexin-A orexin-B sleep disorders narcolepsy humans animals rodents energy homeostasis pain stress antagonists drugs addictions withdrawals therapeutics obesity Surface transfection and expression protocols solid phase transient transfection technology originus patents USPT US6897067 US6902933 US7056741 US 6897067 6902933 7056741 DNA deoxyribonucleases adherent cells receptor-mediated luminescent secretory alkaline phosphatases SEAP signal transduction cascades culture medium luminescence-based high throughput screening screens agonists |
1.019337016574
|
| 700560 |
PAD4 Inhibitor Screening Assay Kit
|
|
- |
|
|
|
2011-05-04
|
27.041660720405
|
pad4-inhibitor-screening-assay-kit
|
Protein Arginine Deiminase 4; Peptidylarginine Deiminase 4
|
kits assays measures measurements proteins arginines deiminases PADs guanidine-modifying enzymes peptidylarginine deiminase amidinotransferases nucleus homodimers transcriptional coregulator catalyzes residues citrulline calcium-dependent substrates histones H2A H3 H4 post-translational modifications genes regulations autocitrullination inhibits enzymatic activity cells rheumatoid arthritis citrulline-containing immune response autoantibodies tissues multiple sclerosis Alzheimer's diseases glaucoma cancers human deiminates N-α-benzoyl-L-arginine ethyl esters BAEE kinetic ammonia detectors fluorescent fluorescence |
27.041660720405
|
| 10218 |
PCSK9 Monoclonal Antibody (Clone 15A6)
|
|
- |
|
|
|
2008-10-29
|
13.274198895027
|
pcsk9-monoclonal-antibody-clone-15a6
|
Proprotein Convertase Subtilisin Kexin 9; NARC-1
|
antibodies proproteins serine protease lipoproteins LDLs low density neural apoptosis-regulated convertase 1 blotting ligands western immunoblotting WB blots |
13.274198895027
|
| 10010518 |
PD 146176
|
|
4079-26-9 |
≥98%
|
|
|
2009-02-25
|
31.652648041431
|
pd-146176
|
NSC 168807
|
atherosclerosis 15-LOs 15-lipoxygenases oxidant injury injuries apoptosis amyloid β proteins inhibitors inhibits inhibitions Alzheimers disease oxidative stress pd146176 |
31.652648041431
|
| 512031 |
Prostaglandin D2 EIA Kit
|
|
- |
|
|
|
2010-07-19
|
268.101938305709
|
prostaglandin-d2-eia-kit
|
PGD2 ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
268.101938305709
|
| 512041 |
Prostaglandin D2 Express EIA Kit
|
|
- |
|
|
|
2010-07-19
|
125.652167445813
|
prostaglandin-d2-express-eia-kit
|
PGD2 Express ELISA Kit
|
PGD2 prostaglandins measures kits eias enzyme immunoassays ELISAs measurements brains glutathione-independent lipocalin-type synthases L-PGDS cerebrospinal fluid CSF physiologic sleep rats humans mast cells leukocytes intracellular myeloid-type glutathione-dependent vascular 11β-PGF2α eicosanoids cultures lysates biosynthesis serum proteins albumin media medium methoximine derivatives PGD2-MOX competitive enzymatic reactions |
125.652167445813
|
| 10012554 |
Resolvin D1
Exclusive |
|
872993-05-0 |
≥95%
|
|
✓ |
2008-06-06
|
256.881973164956
|
resolvin-d1
|
RvD1; 17(S)-Resolvin D1
|
EPA DHA inflammation antiinflammatory anti-inflammatory immune responses aspirin LOX peritonitis LOS neurochemistry resolvins |
256.881973164956
|
| 13332 |
(S)-Glycyl-H-1152 (hydrochloride)
Exclusive |
|
913844-45-8 |
≥98%
|
|
✓ |
2010-01-27
|
51.846950276243
|
-s-glycyl-h-1152-hydrochloride
|
Rho Kinase Inhibitor IV
|
Rho kinases ROCK-I p160ROCK ROCK-II G protein Rho cytoskeletons adhesions proliferation smooth muscles contraction stem cells inhibitors inhibition inhibited Fasudil hydrochloride ROCK IV h1152 h-1152 h 1152 |
51.846950276243
|
| 10011382 |
sPLA2 (human Type IIA) Western Ready Control
Exclusive |
|
- |
|
|
✓ |
2008-03-17
|
32.325840568271
|
spla2-human-type-iia-western-ready-control
|
Secretory Phospholipase A2 (human Type IIA); sPLA2 (human synovial)
|
WB western blots blotting immunoblotting |
32.325840568271
|
| 11190 |
Termitomycamide B
New |
|
1254277-89-8 |
≥97%
|
|
|
2012-01-31
|
173.333333333333
|
termitomycamide-b
|
|
mushrooms extracts ER stress apoptosis endoplasmic reticulum neuroscience proteins misfolding Parkinson’s diseases Alzheimer’s prions fatty acids cells death termites termitomycamides Termitomyces titanicus Neuro2a |
173.333333333333
|
| 13237 |
Thiamet G
Exclusive |
|
1009816-48-1 |
≥97%
|
|
✓ |
2009-06-25
|
34.702679558011
|
thiamet-g
|
|
inhibitors inhibits inhibitions tau alzheimers disease O-GlcNAc OGlcNAc O-GlcNAcase OGlcNAcase O-GlcNAcylation OGlcNAcylation Thiamet-G |
34.702679558011
|
| 10009085 |
U-18666A
|
|
3039-71-2 |
>95%
|
|
|
2007-01-19
|
30.859149171270
|
u-18666a
|
|
Niemann-Pick type C NPC apoptosis neuronal death Alzheimers AD neurodegeneratives diseases trafficking unesterified ER cells membranes cateracts epilepsy Free cholesterol loading NSC 70801 Endoplasmic reticulum atherosclerosis inhibits inhibitors inhibition endosomes lysomes oxidosqualene cyclases atherosclerosis |
30.859149171270
|
| 13033 |
Valproic Acid (sodium salt)
|
|
1069-66-5 |
≥95%
|
|
|
2009-10-21
|
27.022965009207
|
valproic-acid-sodium-salt
|
Sodium Valproate; 2-Propylvaleric Acid
|
valeric acids anticonvulsant seizures inhibitors histones deacetylases HDAC glycogen synthase kinases GSK3 inositol-1,4,5-trisphosphate IP3 combination therapy cancers Alzheimer's diseases stem differentiation self-renewal |
27.022965009207
|
| 10790 |
Xanomeline oxalate
|
|
141064-23-5 |
≥98%
|
|
|
2011-06-14
|
0.382872928177
|
xanomeline-oxalate
|
Lumeron; Memcor; LY246708
|
agonists muscarinic receptors acetylcholine psychosis antipsychotic memory neurotransmitters neurological Alzheimer’s diseases M1-preferring |
0.382872928177
|
| 10229 |
β-Amyloid (1-8, A2V) Peptide
Exclusive |
|
- |
|
|
✓ |
2009-05-08
|
44.783863950276
|
-amyloid-1-8-a2v-peptide
|
Aβ; β-amyloid (1-8) dominant negative; Aβ 1-8 mutant
|
peptides fibrils antibodies inhibitors amyloid .beta. betaamyloid aggregation inhibitors |
44.783863950276
|
| 10241 |
β-Amyloid (1-8) Peptide
Exclusive |
|
- |
|
|
✓ |
2009-06-30
|
50.802967640094
|
-amyloid-1-8-peptide
|
Aβ
|
peptides fibrils antibodies inhibitors amyloid .beta. |
50.802967640094
|